← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Genetica, Inc.
Cambridge, MA
$4,798,025
Total funding
9
Grants
Funding mix
By agency
NIH$4,798,025 · 9
By mechanism
R44$2,182,454 · 4
U01$2,025,196 · 1
R43$490,375 · 3
R41$100,000 · 1
Investigators at Genetica, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
EARLY DIAGNOSIS OF CANCER: THE CANFIND CONSORTIUM$695,047
U01 · FY2002 · CA
EARLY DIAGNOSIS OF CANCER: THE CANFIND CONSORTIUM$674,903
U01 · FY2001 · CA
EARLY DIAGNOSIS OF CANCER: THE CANFIND CONSORTIUM$655,246
U01 · FY2000 · CA
A GENETIC APPROACH TO DRUG FUNCTION$425,671
R44 · FY2002 · GM
A GENETIC APPROACH TO DRUG FUNCTION$413,696
R44 · FY2001 · GM
IMPROVED VECTORS FOR THERAPEUTIC PROTEIN PRODUCTION$379,356
R44 · FY2001 · HL
IMPROVED VECTORS FOR THERAPEUTIC PROTEIN PRODUCTION$367,422
R44 · FY2000 · HL
Stable suppression of gene function in mammals by RNAi$343,000
R44 · FY2002 · CA
A Systematic Approach to Early Diagnosis of Cancer$253,309
R44 · FY2002 · CA
EX-VIVO EXPANSION OF HUMAN PANCREATIC EPITHELIAL CELLS$206,380
R43 · FY2000 · DK
ISOLATION OF TARGETS FOR ANTIFUNGAL DRUGS IN C. ALBICANS$183,995
R43 · FY2000 · AI
RETROTRANSPOSON INSERTIONAL MUTAGENESIS OF MOUSE$100,000
R41 · FY2000 · DE
RNAi in Mammalian Cells$100,000
R43 · FY2002 · GM